Peer Review reports
From: Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
| Original Submission | ||
|---|---|---|
| 12 Jan 2022 | Submitted | Original manuscript |
| 20 Jan 2022 | Author responded | Author comments - Chenxing Wang |
| Resubmission - Version 2 | ||
| 20 Jan 2022 | Submitted | Manuscript version 2 |
| 1 Feb 2022 | Author responded | Author comments - Chenxing Wang |
| Resubmission - Version 3 | ||
| 1 Feb 2022 | Submitted | Manuscript version 3 |
| 22 Apr 2022 | Reviewed | Reviewer Report |
| 1 Jun 2022 | Reviewed | Reviewer Report |
| 13 Jun 2022 | Author responded | Author comments - Chenxing Wang |
| Resubmission - Version 4 | ||
| 13 Jun 2022 | Submitted | Manuscript version 4 |
| 15 Jun 2022 | Reviewed | Reviewer Report |
| 24 Jun 2022 | Reviewed | Reviewer Report |
| 5 Jul 2022 | Author responded | Author comments - Chenxing Wang |
| Resubmission - Version 5 | ||
| 5 Jul 2022 | Submitted | Manuscript version 5 |
| Publishing | ||
| 13 Jul 2022 | Editorially accepted | |
| 26 Jul 2022 | Article published | 10.1186/s12885-022-09901-w |
You can find further information about peer review here.